Epicardial and Pericardial Fat in Type 2 Diabetes: Favourable Effects of Biliopancreatic Diversion

Obesity Surgery

Volumn 25, Issue 3, 2015, Pages 477-485

  Vasques, Ana Carolina Junqueira ^a   Pareja, José Carlos ^a   Souza, José Roberto Mattos ^a   Yamanaka, Ademar ^a   de Oliveira, Maria da Saúde ^a   Novaes, Fernanda Satake ^a   Chaim, Élinton Adami ^a   Piccinini, Francesca ^b   Dalla Man, Chiara ^b   Cobelli, Claudio ^b   Geloneze, Bruno ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Biliopancreatic diversion surgery; Epicardial adipose tissue; Hyperglycaemic clamp; Insulin sensitivity; Obesity; Type 2 diabetes mellitus

Indexed keywords

ADIPONECTIN; GLYCOSYLATED HEMOGLOBIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BILIOPANCREATIC BYPASS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC OBESITY; ECHOGRAPHY; EPICARDIAL ADIPOSE TISSUE; FAT BODY; FEMALE; GLUCOSE TOLERANCE; HUMAN; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LEAN BODY WEIGHT; LIPID STORAGE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERICARDIAL ADIPOSE TISSUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUBCUTANEOUS FAT; TREATMENT OUTCOME; COMPLICATION; DIABETES MELLITUS, TYPE 2; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PERICARDIUM; PHYSIOLOGY;

ADIPOSE TISSUE; ADIPOSITY; ADULT; BILIOPANCREATIC DIVERSION; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY; PERICARDIUM; SUBCUTANEOUS FAT;

EID: 84943015293     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-014-1400-1     Document Type: Article

References (29)

1. Bays HE. Adiposopathy is “sick fat” a cardiovascular disease? J Am Coll Cardiol. 2011;57:2461–73.
2. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet. 2011;378:169–81.
3. Britton KA, Fox CS. Ectopic fat depots and cardiovascular disease. Circulation. 2011;124:e837–41.
4. Wajchenberg BL, Giannella-Neto D, da Silva ME, et al. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2002;34:616–21.
5. Iacobellis G, Malavazos AE, Corsi MM. Epicardial fat: from the biomolecular aspects to the clinical practice. Int J Biochem Cell Biol. 2011;43:1651–4.
6. Chen X, Jiao Z, Wang L, et al. Roles of human epicardial adipose tissue in coronary artery atherosclerosis. J Huazhong Univ Sci Technol Med Sci. 2010;30:589–93.
7. Standards of medical care in diabetes--2012. Diabetes Care 2012;35:dc12–s011.
8. Dixon JB, Zimmet P, Alberti KG, et al. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Arq Bras Endocrinol Metabol. 2011;55:367–82.
9. Dixon JB, le Roux CW, Rubino F, et al. Bariatric surgery for type 2 diabetes. Lancet. 2012;379(9833):2300–11.
10. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56.
11. Mari A, Manco M, Guidone C, et al. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function. Diabetologia. 2006;49(9):2136–43.
12. Scopinaro N, Adami GF, Papadia FS, et al. The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30–35 kg/m2) and simple overweight (BMI 25–30 kg/m2): a prospective controlled study. Obes Surg. 2011;21(7):880–8.
13. Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes. 2006;55(7):2025–31.
14. Executive summary: standards of medical care in diabetes--2012. Diabetes Care 2012;35(Suppl 1):S4–S10
15. Scopinaro N, Gianetta E, Civalleri D, et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979;66(9):618–20.
16. Ribeiro-Filho FF, Faria AN, Azjen S, et al. Methods of estimation of visceral fat: advantages of ultrasonography. Obes Res. 2003;11(12):1488–94.
17. Iacobellis G, Assael F, Ribaudo MC, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res. 2003;11(2):304–10.
18. Iacobellis G. Epicardial and pericardial fat: close, but very different. Obesity (Silver Spring). 2009;17(4):625.
19. Mitrakou A, Vuorinen-Markkola H, Raptis G, et al. Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemia clamp. J Clin Endocrinol Metab. 1992;75(2):379–82.
20. Cobelli C, Caumo A, Omenetto M. Minimal model SG overestimation and SI underestimation: improved accuracy by a Bayesian two-compartment model. Am J Physiol. 1999;277(3 Pt 1):E481–8.
21. Gaborit B, Jacquier A, Kober F, et al. Effects of bariatric surgery on cardiac ectopic fat: lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content. J Am Coll Cardiol. 2012;60(15):1381–9.
22. Willens HJ, Byers P, Chirinos JA, et al. Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography. Am J Cardiol. 2007;99(9):1242–5.
23. Greco AV, Mingrone G, Giancaterini A, et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes. 2002;51(1):144–51.
24. Capurso C, Capurso A. From excess adiposity to insulin resistance: the role of free fatty acids. Vascul Pharmacol. 2012;57(2–4):91–7.
25. Vasques AC, Souza JR, Yamanaka A, et al. Sagittal abdominal diameter as a marker for epicardial adipose tissue in premenopausal women. Metabolism. 2013;62(7):1032–6.
26. Salani B, Briatore L, Andraghetti G, et al. High-molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects. Obesity. 2006;14(9):1511–4.
27. Salinari S, Bertuzzi A, Asnaghi S, et al. First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care. 2009;32(3):375–80.
28. Lima MM, Pareja JC, Alegre SM, et al. Acute effect of Roux-en-Y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(8):3871–5.
29. Laferrere B. Diabetes remission after bariatric surgery: is it just the incretins? Int J Obes. 2011;35(3):143.